Health
Internal AstraZeneca safety report sheds light on neurological condition suffered by vaccine trial participant – CTV News
An internal safety report by pharmaceutical giant AstraZeneca describes how a participant in its vaccine trial developed trouble walking, weakness and pain in her arms, and other symptoms.
CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the participants in its coronavirus vaccine clinical trial.
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5.
Four days later, AstraZeneca dismissed media reports about the participant havin…
-
General10 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General13 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Noosa News23 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
General23 hours agoNZ government’s puberty blockers move attracts strong reactions